|
Jun 19
|
Transgene Completes Initial Patient Screening in Phase II Part of TG4050 Trial in Operable Head and Neck Cancer
|
|
Jun 13
|
Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders
|
|
Apr 10
|
Availability of Transgene’s 2024 Universal Registration Document (URD)
|
|
Oct 7
|
Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024
|
|
Dec 21
|
Transgene Announces Upcoming Investor Meetings
|
|
Dec 5
|
Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy
|
|
Nov 7
|
Transgene Reports Business Update and Q3 2023 Financial Position
|
|
Sep 7
|
One Biosciences announces the appointment of Hedi Ben Brahim as Chief Executive Officer
|